These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23980031)

  • 1. Directed evolution of the TALE N-terminal domain for recognition of all 5' bases.
    Lamb BM; Mercer AC; Barbas CF
    Nucleic Acids Res; 2013 Nov; 41(21):9779-85. PubMed ID: 23980031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric TALE recombinases with programmable DNA sequence specificity.
    Mercer AC; Gaj T; Fuller RP; Barbas CF
    Nucleic Acids Res; 2012 Nov; 40(21):11163-72. PubMed ID: 23019222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TALE: a tale of genome editing.
    Zhang M; Wang F; Li S; Wang Y; Bai Y; Xu X
    Prog Biophys Mol Biol; 2014 Jan; 114(1):25-32. PubMed ID: 24291598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the transcription activator-like effectors scaffold versatility to expand the toolbox of designer nucleases.
    Juillerat A; Beurdeley M; Valton J; Thomas S; Dubois G; Zaslavskiy M; Mikolajczak J; Bietz F; Silva GH; Duclert A; Daboussi F; Duchateau P
    BMC Mol Biol; 2014 Jul; 15():13. PubMed ID: 24997498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies.
    Gersbach CA; Gaj T; Barbas CF
    Acc Chem Res; 2014 Aug; 47(8):2309-18. PubMed ID: 24877793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the TALE repeat.
    Deng D; Yan C; Wu J; Pan X; Yan N
    Protein Cell; 2014 Apr; 5(4):297-306. PubMed ID: 24622844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAPTA: a new design tool for improving TALE nuclease activity.
    Lin Y; Fine EJ; Zheng Z; Antico CJ; Voit RA; Porteus MH; Cradick TJ; Bao G
    Nucleic Acids Res; 2014 Apr; 42(6):e47. PubMed ID: 24442582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering customized TALE nucleases (TALENs) and TALE transcription factors by fast ligation-based automatable solid-phase high-throughput (FLASH) assembly.
    Reyon D; Maeder ML; Khayter C; Tsai SQ; Foley JE; Sander JD; Joung JK
    Curr Protoc Mol Biol; 2013 Jul; Chapter 12():Unit 12.16. PubMed ID: 23821439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.
    Mussolino C; Morbitzer R; Lütge F; Dannemann N; Lahaye T; Cathomen T
    Nucleic Acids Res; 2011 Nov; 39(21):9283-93. PubMed ID: 21813459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity.
    Guilinger JP; Pattanayak V; Reyon D; Tsai SQ; Sander JD; Joung JK; Liu DR
    Nat Methods; 2014 Apr; 11(4):429-35. PubMed ID: 24531420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the specificity of transcription activator-like effector nucleases.
    Juillerat A; Dubois G; Valton J; Thomas S; Stella S; Maréchal A; Langevin S; Benomari N; Bertonati C; Silva GH; Daboussi F; Epinat JC; Montoya G; Duclert A; Duchateau P
    Nucleic Acids Res; 2014 Apr; 42(8):5390-402. PubMed ID: 24569350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases.
    Mandell JG; Barbas CF
    Nucleic Acids Res; 2006 Jul; 34(Web Server issue):W516-23. PubMed ID: 16845061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous directed evolution of DNA-binding proteins to improve TALEN specificity.
    Hubbard BP; Badran AH; Zuris JA; Guilinger JP; Davis KM; Chen L; Tsai SQ; Sander JD; Joung JK; Liu DR
    Nat Methods; 2015 Oct; 12(10):939-42. PubMed ID: 26258293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmable DNA-binding proteins from Burkholderia provide a fresh perspective on the TALE-like repeat domain.
    de Lange O; Wolf C; Dietze J; Elsaesser J; Morbitzer R; Lahaye T
    Nucleic Acids Res; 2014 Jun; 42(11):7436-49. PubMed ID: 24792163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TALE-PvuII fusion proteins--novel tools for gene targeting.
    Yanik M; Alzubi J; Lahaye T; Cathomen T; Pingoud A; Wende W
    PLoS One; 2013; 8(12):e82539. PubMed ID: 24349308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multiplexed transcription activator-like effector system for detecting specific DNA sequences.
    Honarmand A; Mayall R; George I; Oberding L; Dastidar H; Fegan J; Chaudhuri S; Dole J; Feng S; Hoang D; Moges R; Osgood J; Remondini T; van der Meulen WK; Wang S; Wintersinger C; Zaparoli Zucoloto A; Chatfield-Reed K; Arcellana-Panlilio M; Nygren A
    ACS Synth Biol; 2014 Dec; 3(12):953-5. PubMed ID: 25524096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creating a TALE protein with unbiased 5'-T binding.
    Tsuji S; Futaki S; Imanishi M
    Biochem Biophys Res Commun; 2013 Nov; 441(1):262-5. PubMed ID: 24148249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains.
    Cong L; Zhou R; Kuo YC; Cunniff M; Zhang F
    Nat Commun; 2012 Jul; 3():968. PubMed ID: 22828628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of TALE-DNA interactions suggests polarity effects.
    Meckler JF; Bhakta MS; Kim MS; Ovadia R; Habrian CH; Zykovich A; Yu A; Lockwood SH; Morbitzer R; Elsäesser J; Lahaye T; Segal DJ; Baldwin EP
    Nucleic Acids Res; 2013 Apr; 41(7):4118-28. PubMed ID: 23408851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TALENs: a widely applicable technology for targeted genome editing.
    Joung JK; Sander JD
    Nat Rev Mol Cell Biol; 2013 Jan; 14(1):49-55. PubMed ID: 23169466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.